참고문헌
- Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004;34:501-537. https://doi.org/10.1016/j.semarthrit.2004.07.002
- Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
- Jung JY, Koh BR, Kim HA, Jeon JY, Suh CH. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus. J Investig Med 2014;62:890-893. https://doi.org/10.1097/JIM.0000000000000094
- Zuniga R, Markowitz GS, Arkachaisri T, Imperatore EA, D'Agati VD, Salmon JE. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles. Arthritis Rheum 2003;48:460-470. https://doi.org/10.1002/art.10930
- Sjowall C, Bengtsson AA, Sturfelt G, Skogh T. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther 2004;6;R87-R94. https://doi.org/10.1186/ar1032
- Tan Y, Yu F, Yang H, Chen M, Fang Q, Zhao MH. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions. Hum Immunol 2008;69:840-844. https://doi.org/10.1016/j.humimm.2008.09.006
- Sjowall C, Zickert A, Skogh T, Wettero J, Gunnarsson I. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res Ther 2009;11:R188. https://doi.org/10.1186/ar2880
- O'Neill SG, Giles I, Lambrianides A, et al. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2010;62:845-854. https://doi.org/10.1002/art.27286
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
- Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-250. https://doi.org/10.1097/01.ASN.0000108969.21691.5D
- Suh CH, Chun HY, Ye YM, Park HS. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Clin Immunol 2006;119:291-296. https://doi.org/10.1016/j.clim.2005.11.006
- Suh CH, Jeong YS, Park HC, et al. Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol 2001;19:191-194.
- Sjowall C, Eriksson P, Almer S, Skogh T. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmun 2002;19:155-160. https://doi.org/10.1006/jaut.2002.0608
- Rosenau BJ, Schur PH. Antibodies to C reactive protein. Ann Rheum Dis 2006;65:674-676. https://doi.org/10.1136/ard.2005.037895
- Shoenfeld Y, Szyper-Kravitz M, Witte T, et al. Autoantibodies against protective molecules. C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007;1108:227-239. https://doi.org/10.1196/annals.1422.025
- Meyer O. Anti-CRP antibodies in systemic lupus erythematosus. Joint Bone Spine 2010;77:384-389. https://doi.org/10.1016/j.jbspin.2010.04.010
- Pradhan V, Rajadhyaksha A, Yadav K, et al. Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus. Indian J Nephrol 2013;23:434-437. https://doi.org/10.4103/0971-4065.120341
피인용 문헌
- Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients vol.66, pp.5, 2018, https://doi.org/10.1007/s00005-018-0513-y
- Infections in hospitalized children with newly diagnosed systemic lupus erythematosus in underresourced areas vol.29, pp.11, 2018, https://doi.org/10.1177/0961203320939164
- Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? vol.11, pp.None, 2018, https://doi.org/10.3389/fimmu.2020.626343
- Recurrent lupus enteritis in a child-chase the calm before the storm vol.30, pp.12, 2021, https://doi.org/10.1177/09612033211045923